CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 14.89×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)
- FinancialsAltman Z-Score 6.77: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.35%
Annual Rate
CNY 0.06Paid annual
Payout Ratio
32.4%Sustainable
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
5.48BCNY815.59M · vs all stocks (USD)
Trailing P/E
126.54xvs Medical Instruments & Supplies peers
Revenue (TTM)
666.99MCNY99.19M · vs all stocks (USD)
Profit Margin
7.09%vs Medical Instruments & Supplies peers
Beta
0.5100xvs all stocks
52-Week Change
-37.49%vs all stocks
Market Capitalization
5.48BCNY815.59M · vs all stocks (USD)
Enterprise Value
2.98BCNY443.03M · vs all stocks (USD)
Trailing P/E
126.54xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
8.50xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.34xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.47xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
125.34xvs Medical Instruments & Supplies peers
Gross Margin
21.31%vs Medical Instruments & Supplies peers
Profit Margin
7.09%vs Medical Instruments & Supplies peers
Operating Margin
-4.19%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.35%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.12%vs Medical Instruments & Supplies peers
Revenue (TTM)
666.99MCNY99.19M · vs all stocks (USD)
Revenue per Share (TTM)
1.92CNYUpdated Aug 21, 2026Quarterly Revenue Growth
59.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
164.93MCNY24.53M · vs all stocks (USD)
EBITDA (TTM)
105.67MCNY15.71M · vs all stocks (USD)
Net Income (TTM)
47.30MCNY7.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
240.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-9.79MCNY-1.46M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-516.60MCNY-76.82M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0560CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.35%vs all stocks
Payout Ratio
32.39%vs Medical Instruments & Supplies peers
Revenue
628.32MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
471.72MCNYFY2025 · Dec 31, 2025Gross Profit
156.60MCNYFY2025 · Dec 31, 2025Operating Income
11.47MCNY1.71M · vs all stocks (USD)
Pre-tax Income
45.52MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.75MCNYFY2025 · Dec 31, 2025Net Income
42.78MCNYFY2025 · Dec 31, 2025EBIT
45.59MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
105.67MCNYFY2025 · Dec 31, 2025Research & Development
58.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.92MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
64.77KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
356.48MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
356.48MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
42.78MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
92.96MCNYFY2025 · Dec 31, 2025Free Cash Flow
62.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.52BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
42.78MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.89MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-21.26MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
67.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-30.73MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.10BCNYFY2025 · Dec 31, 2025Sale of Investments
1.81BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
681.62MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.14MCNYFY2025 · Dec 31, 2025Other Financing Charges
-672.71KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-49.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
344.50MSharesUpdated Aug 21, 2026Float Shares
91.71MSharesUpdated Aug 21, 2026% Held by Insiders
73.40%vs all stocks
% Held by Institutions
3.75%vs all stocks
Total Cash (MRQ)
2.50BCNY371.04M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.24CNYUpdated Aug 21, 2026Total Debt (MRQ)
102.50KCNY15.24K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0000xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
14.89xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.29CNYUpdated Aug 21, 2026Total Assets
4.81BCNY715.65M · vs all stocks (USD)
Total Current Assets
3.90BCNYFY2025 · Dec 31, 2025Total Liabilities
584.78MCNYFY2025 · Dec 31, 2025Total Non-current Assets
909.81MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
286.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
297.81MCNYFY2025 · Dec 31, 2025Cash
2.11BCNYFY2025 · Dec 31, 2025Cash Equivalents
405.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.52BCNYFY2025 · Dec 31, 2025Accounts Receivable
608.17MCNYFY2025 · Dec 31, 2025Inventory
156.57MCNYFY2025 · Dec 31, 2025Accounts Payable
250.21MCNYFY2025 · Dec 31, 2025Short-term Debt
452.94KCNYFY2025 · Dec 31, 2025Other Current Liabilities
603.60KCNYFY2025 · Dec 31, 2025Common Stock (Book)
344.50MCNYFY2025 · Dec 31, 2025Retained Earnings
271.40MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.23BCNY628.69M · vs all stocks (USD)
52-Week Low
13.68CNYUpdated Aug 21, 202652-Week High
25.67CNYUpdated Aug 21, 202652-Week Change
-37.49%vs all stocks
Beta
0.5100xvs all stocks
50-Day MA
15.78CNYUpdated Aug 21, 2026200-Day MA
19.37CNYUpdated Aug 21, 2026Avg 10-Day Volume
4.90MSharesUpdated Aug 21, 2026Avg 30-Day Volume
5.05MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1300CNYUpdated Aug 21, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 14.89×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 14.89Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
P/E ratio is 126.54×, higher than 95% of its Medical Instruments & Supplies peers (median 30.34×)Significant
P/E ratio: 126.538Industry median: 30.34Industry P95: 123.965Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 7,034,285.179Operating Cash Flow (USD, TTM): -1,455,678.321
Financial Health
Altman Z-Score 6.77: safe zoneNotable
Altman Z-Score: 6.77
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Maharashtra Seamless Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Nengter Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Newonder Special Electric Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
BALLARD POWER SYSTEMS INC Common Stock
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Xinpeng Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CW Enerji Mühendislik Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Hongchang Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hiconics Eco-Energy Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
DL Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Lsb Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Sichuan Newsnet Media Group Co., Ltd.
6 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios ElevatedPrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationCash Backing With OCF Coverage And Cash Near Total Debt
Shenyu Communication Technology Co., Ltd.
5 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios ElevatedPrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration
Hangzhou Onechance Technology Co., Ltd.
5 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationCash Backing With OCF Coverage And Cash Near Total Debt